We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.20 | 2.00 | 2.40 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMODX
RNS Number : 9918L
Omega Diagnostics Group PLC
24 April 2018
Omega Diagnostics Group PLC
("Omega" or the "Company")
PDMR Dealing
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it was notified on 24 April 2018 that Edward Valente, Group R&D Director of the Company has purchased 124,044 ordinary shares of 4 pence each in the capital of the Company ("Ordinary Shares") at a price of 14.5 pence per Ordinary Share.
Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):
1) Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') a) Name Edward Valente 2. Reason for notification b) Position / Group R&D Director status c) Initial notification Initial Notification / amendment 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor b) Name Omega Diagnostics Group plc c) LEI 2138007U9P4BTZTYIR92 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description Purchase of Ordinary Shares of the financial GB00B1VCP282 instrument Identification code b) Nature of Purchase of Ordinary Shares the transaction c) Price(s) and Volume(s) Price(s) GBP volume(s) 124,044 0.145 d) Aggregated Aggregate Volume(s) Volume weighted information average Price) Aggregated GBP volume Price 124,044 0.145 e) Date of the 24/04/18 transaction f) Place of the LSE transaction
Contacts:
Omega Diagnostics Group Tel: 01259 763 030 PLC Colin King, Chief Executive www.omegadiagnostics.com Kieron Harbinson, Group Finance Director Jag Grewal, Group Sales and Marketing Director finnCap Ltd Tel: 020 7220 0500 Geoff Nash/James Thompson (Corporate Finance) Camille Gochez (Corporate Broking) Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com Paul McManus Mob: 07980 541 893 Lianne Cawthorne Mob: 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHFKQDKABKDBQB
(END) Dow Jones Newswires
April 24, 2018 12:04 ET (16:04 GMT)
1 Year Omega Diagnostics Chart |
1 Month Omega Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions